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AMPA receptor (AMPA-R) complexes consist of
channel-forming subunits, GluA1-4, and auxiliary
proteins, including TARPs, CNIHs, synDIG1, and
CKAMP44, which can modulate AMPA-R function
in specific ways. The combinatorial effects of four
GluA subunits binding to various auxiliary subunits
amplify the functional diversity of AMPA-Rs. The
significance and magnitude of molecular diversity,
however, remain elusive. To gain insight into the
molecular complexity of AMPA and kainate recep-
tors, we compared the proteins that copurify with
each receptor type in the rat brain. This interactome
study identified the majority of known interacting
proteins and, more importantly, provides candidates
for additional studies. We validate the claudin
homolog GSG1L as a newly identified binding
protein and unique modulator of AMPA-R gating,
as determined by detailed molecular, cellular,
electrophysiological, and biochemical experiments.
GSG1L extends the functional variety of AMPA-R
complexes, and further investigation of other candi-
dates may reveal additional complexity of ionotropic
glutamate receptor function.INTRODUCTION
AMPA receptors (AMPA-Rs) and kainate receptors (KA-Rs) are
members of the ionotropic glutamate receptor (iGluR) family,
functioning as ligand-gated ion channels that mediate excitatory
synaptic transmission and plasticity in the brain (Traynelis et al.,
2010). Their functions are regulated by the composition of
channel-forming core subunits, association with auxiliary590 Cell Reports 1, 590–598, June 28, 2012 ª2012 The Authorsproteins, phosphorylation, receptor trafficking, and interaction
with cytoplasmic scaffolds (Jackson and Nicoll, 2011; Kim and
Sheng, 2004; Shepherd and Huganir, 2007). Defining molecules
that mediate receptor modulation is critical in understanding
basic brain function and disease mechanisms. The molecular
composition of AMPA-Rs and KA-Rs is diverse, and the
complete landscape is currently unclear.
The iGluR’s channel core is a tetrameric assembly of receptor
subunits, GluA1-4 for AMPA-Rs and GluK1-5 for KA-Rs
(Collingridge et al., 2009). Auxiliary transmembrane subunits
bind to core iGluR subunits. They are found across species
(Wang et al., 2008) and include stargazin/transmembrane
AMPA-R regulatory proteins (stg/TARPs) (Chen et al., 2000; To-
mita et al., 2003), SOL-1 (Zheng et al., 2004), cornichon2/3
(CNIH-2/3) (Schwenk et al., 2009), synDIG1 (Kalashnikova
et al., 2010), and CKAMP44 (von Engelhardt et al., 2010) for
AMPA-Rs and Neto1/2 (Zhang et al., 2009) for KA-Rs. The
combinatorial effect of various auxiliary subunits binding to
channel-forming core subunits extends the architectural and
functional complexity of iGluRs in the brain (Farrant and Cull-
Candy, 2010; Jackson and Nicoll, 2011).
iGluR complexes are extensively studied, yet new binding
proteins are continuously reported. Biochemical hurdles in
handling intact membrane proteins have been overcome for
AMPA-Rs and KA-Rs by robust purification protocols (Naka-
gawa et al., 2005; Zhang et al., 2009). In combination with liquid
chromatographic separations in line with tandem mass spec-
trometers, peptide analysis can identify nearly all proteins
present in a low-complexity sample (Savas et al., 2011).
In this study, we wished to identify iGluR interactors that are
less abundant or difficult to find. Specifically, we compared the
interactomes of native AMPA-Rs and KA-Rs and identified an
AMPA-R auxiliary subunit, GSG1L. GSG1L modifies AMPA-R
channel function very differently from the known auxiliary modu-
lators, revealing another functional repertoire of AMPA-Rs. This
study provides a proof-of-principal for identifying novel interac-
tors of iGluRs with the use of our interactome data. Our results
may also reveal previously unexpected molecular and functional
diversity of iGluR complexes.
RESULTS
Identification of Candidate Proteins that Copurify
with AMPA-Rs and KA-Rs in Rat Brain
We performed immunoaffinity purification of native AMPA-Rs
and KA-Rs followed by shotgun liquid chromatography-tandem
mass spectrometry (LC-MS/MS) protein analysis (AP-MS/MS).
The copurifying proteins were directly analyzed by multidimen-
sional protein identification technology (MudPIT) (Washburn
et al., 2001). As a negative control, we performed a parallel
purification with normal rabbit IgG. Any protein binding to IgG
was excluded from analysis.
A summary and complete list of the proteins that copurify with
brain AMPA-Rs and KA-Rs are shown in Tables 1 and S1,
respectively. Our purification was highly enriched for the target
proteins containing the epitopes of the antibodies used for
affinity purification, as demonstrated by numerous spectrum
counts (s.c.) and peptide counts (p.c.) for GluA2 (2526 s.c., 193
p.c.) and GluK2 (790 s.c., 88 p.c.). Nearly all known AMPA-R
interacting membrane proteins, such as TARPs (stg/g-2, g-3,
g-4, g-5, g-7, and g-8), CNIH-2/3, andCKAMP44, were identified
in our AMPA-R preparation. Although we did not find synDIG1
itself, we identified homologs (Tables 1 and S1). Among the
known auxiliary subunits, stg/TARPs were most abundantly
detected, whereas fewer s.c.’s and p.c’s were observed
for the others. Furthermore, the known KA-R auxiliary sub-
units Neto1 and Neto2 were detected with KA-Rs (Tables 1
and S1). These results indicate that our purification was robust,
and therefore, further investigation of the list may identify other
interactors. Our results extend the current knowledge of the
interactomes of AMPA-Rs and KA-Rs.
Predicted Protein GSG1L Is Expressed the Brain
and Binds to AMPA-Rs
Among the candidates, we focused on the predicted protein
GSG1L, a membrane protein specifically copurifying with
AMPA-Rs (Figure 1A). It is a distant homolog of stg/TARPs
belonging to the extended claudin family (Figure 1B). Further-
more, its peptide counts were comparable to known AMPA-R
auxiliary subunits (Figure 1A and Table 1). GSG1Lwas reproduc-
ibly identified from rat brain (Tables 1 and S1) and also copurified
with AMPA-Rs from human cortex (Figures S1A–S1C), indicative
of evolutionary conservation of the interactome. Collectively, this
evidence provided support for further investigation.
While it is in the claudin family, GSG1L is distinct from stg/
TARPs, as there is a large evolutionary distance between
GSG1L and stg/TARPs. The nearest family member of GSG1L
is the product of germline-specific gene 1 (GSG1), whose tran-
script is specifically expressed in the germline and whose
function is unknown (Tanaka et al., 1994).
Similar to claudins, the predicted topology of GSG1L has
a cytoplasmic N terminus, four transmembrane segments, two
extracellular loops, and a cytoplasmic C terminus (Figure 1C).
Loop1 is50% longer in GSG1L than in TARPs. The extracellular
and cytoplasmic domains of GSG1L are not conserved with stg/TARPs (Figure S1D). These regions are responsible for modu-
lating AMPA-R function in stg/TARPs (Tomita et al., 2005); there-
fore, GSG1L may potentially have a unique modulatory function.
GSG1L was annotated as a predicted protein in the rat
genome. Its protein existence was unknown and two alterna-
tively spliced transcripts were predicted (GenBank entries
XP_002725730.1 and XP_574558.2; predicted molecular
weights 26 and 36 kDa, respectively). The shorter variant lacks
the first 102 amino acids, including the first transmembrane
domain. We first created three polyclonal antibodies against
different epitopes of the predicted GSG1L protein (Figure S1D).
The first epitope, Lp1, is present only in the product of the longer
spliced variant. When we purified native AMPA-Rs from rat brain
tissue and examined GSG1L by Western blot, all three
antibodies detected a band at the molecular weight of 43 kDa,
consistent with the long isoform (Figures 1D1 and 1D2). These
results establish that GSG1L is a protein expressed in rat brain
and copurifies with native AMPA-Rs.
GSG1L Interacts Specifically with AMPA-R Subunits
In Vitro
To reconstitute the interaction in nonneuronal cells, we trans-
fected a plasmid encoding hemagglutinin (HA)-tagged GSG1L
into stable human embryonic kidney (HEK) cell lines that express
either GluA2 or GluK2 and immunoprecipitated the HA-GSG1L
by using an anti-HA antibody. GluA2 coimmunoprecipitated
with GSG1L, whereas GluK2 did not (Figures 1E1 and 1E2).
Under the same conditions, the known KA-R auxiliary subunit
Neto2 specifically interacted with GluK2 but not with GluA2.
Conversely, the specific interaction of GSG1L with GluA2 and
not with GluK2 was also observed when the immunoprecipita-
tion was performed with the use of antibodies directed against
each glutamate receptor subunit (Figures S2A1 and 2). Further-
more, GSG1L and GluA2 partially colocalize near the plasma
membrane when coexpressed in a stable HEK cell line with the
use of a DOX-inducible expression system (Figure 1F). Similar
results were obtained when the two proteins were coexpressed
through transient transfection (Figure S2B). GluA1 also forms
a complex with GSG1L, as determined by coimmunoprecipita-
tion experiments (Figure 1G). These observations establish the
physical interaction between GSG1L and AMPA-R subunits.
Functional Interaction of GSG1L with AMPA-Rs
Next, we investigated functional interactions between GSG1L
and AMPA-Rs. Transfection of GSG1L into a stable HEK cell
line that expresses GluA2 increased the surface expression of
GluA2 as compared to transfecting EGFP. In fact, GSG1L
increased the surface expression of GluA2 as efficiently as stg
(Figures 2A and 2B), indicating that surface expression of
AMPA-Rs is positively modulated by GSG1L.
A functional interaction was also detected by a cell-death
assay (Sans et al., 2003; Shanks et al., 2010) (Figure S3). For
this purpose, we created stable TetON HEK cell lines that
express GluA2 in a DOX-dependent fashion and constitutively
express GSG1L or stg (Figure S3A). Cell death was observed
after GluA2 expression was induced by DOX in the cell line
constitutively expressing stg or GSG1L. Cytotoxicity was
blocked by the AMPA-R antagonist NBQX and was not detectedCell Reports 1, 590–598, June 28, 2012 ª2012 The Authors 591
Table 1. Comparison of AMPA-R and KA-R Interactomes by Mass Spectrometry
IPI GluA2 Spec,Pep (%AA) GluA2 Norm GluK2 Spec,Pep (%AA) GluK2 Norm Common Name
Known Primary Interactors
IPI00780113.1 2526, 193 (71.3), 1.0000 17, 11 (17.2), 0.0215 GluA2
IPI00324555.2 876, 129 (60.4), 0.3468 6, 3 (5.1) 0.0076 GluA1
IPI00231095.1 873, 121 (56.5), 0.3456 6, 4 (4.8) 0.0076 GluA3
IPI00195445.1 585, 91 (48.7), 0.2316 3, 2 (2.4) 0.0038 GluA4
IPI00207460.1 212, 26 (34.0), 0.0839 0, 0 (0.0) 0.0000 TARP gamma-3
IPI00201313.4 193, 28 (39.6), 0.0764 0, 0 (0.0) 0.0000 TARP gamma-2
IPI00207426.1 162, 28 (36.8), 0.0641 5, 2 (8.3) 0.0063 TARP gamma-8
IPI00207431.1 78, 13 (32.4), 0.0309 0, 0 (0.0) 0.0000 TARP gamma-4
IPI00214444.1 11, 4 (23.3), 0.0044 0, 0 (0.0) 0.0000 TARP gamma-7
IPI00207430.1 3, 2 (6.9) 0.0012 0, 0 (0.0) 0.0000 TARP gamma-5
IPI00366152.2 18, 6 (13.1), 0.0071 0, 0 (0.0) 0.0000 CNIH-2
IPI00358957.3 11, 4 (9.0) 0.0044 0, 0 (0.0) 0.0000 CNIH-3
IPI00956073.1 147, 13 (26.2) 0.0582 0, 0 (0.0) 0.0000 Shisa-9/CKAMP-44
IPI00566635.2 255, 61 (65.1), 0.1010 28, 10 (16.0), 0.0354 PSD-95
IPI00777470.1 80, 31 (40.7), 0.0317 208, 62 (62.7), 0.2633 SAP-97
IPI00650099.1 53, 21 (27.9), 0.0210 140, 48 (42.4), 0.1772 PSD-93
IPI00568474.1 28, 14 (19.6), 0.0111 27, 11 (10.0) 0.0342 SAP-102
IPI00208830.1 2, 2 (3.0) 0.0008 0, 0 (0.0) 0.0000 Grip1
IPI00409970.1 0, 0 (0.0) 0.0000 2, 2 (6.3) 0.0025 Grip2
IPI00204506.1 5, 5 (6.7), 0.0020 42, 20 (22.8), 0.0532 protein4.1
IPI00210635.2 16, 13 (19.5), 0.0063 32, 20 (36.0), 0.0405 NSF
IPI00471901.3 11, 6 (8.4), 0.0044 10, 6 (10.2), 0.0127 AP-2 alpha2
IPI00389753.1 6, 6 (9.3), 0.0024 10, 6 (7.6) 0.0127 AP-2 beta
IPI00203346.4 5, 4 (6.3), 0.0020 8, 6 (10.1), 0.0101 AP-2 alpha1
IPI00196530.1 4, 3 (5.7) 0.0016 5, 4 (11.5), 0.0063 AP-2 mu
IPI00198371.1 2, 2 (14.1) 0.0008 4, 3 (24.6) 0.0051 AP-2 sigma
IPI00324708.1 0, 0 (0.0) 0.0000 790, 88 (47.8), 1.0000 GluK2
IPI00207006.1 0, 0 (0.0) 0.0000 190, 52 (48.0), 0.2405 GluK5
IPI00231400.2 0, 0 (0.0) 0.0000 187, 36 (29.1), 0.2367 GluK1
IPI00231277.4 2, 2 (2.2), 0.0008 686, 77 (45.4), 0.8684 GluK3
IPI00326553.1 0, 0 (0.0) 0.0000 105, 32 (34.5), 0.1329 GluK4
IPI00359373.3 0, 0 (0.0) 0.0000 125, 37 (59.7), 0.1582 Neto2
IPI00367046.2 0, 0 (0.0) 0.0000 37, 14 (38.3) 0.0468 Neto1
IPI00370061.1 0, 0 (0.0) 0.0000 19, 14 (22.8), 0.0241 Kelch
Candidate Interactors
IPI00763858.2 0, 0 (0.0) 0.0000 9, 5 (13.3), 0.0114 MAGUK p55
IPI00365736.3 14, 11 (12.0), 0.0055 5, 5 (6.1) 0.0063 Liprin alpha 3
IPI00392157.3 0, 0 (0.0) 0.0000 14, 13 (13.9), 0.0177 Liprin alpha 4
IPI00388795.3 11, 8 (12.6) 0.0044 94, 32 (36.6) 0.1190 CASK
IPI00214300.1 0, 0 (0.0) 0.0000 37, 12 (42.6) 0.0342 Lin 7
IPI00367477.1 56, 21 (29.8), 0.0222 0, 0 (0.0) 0.0000 NGL-3 (LRRC 4b)
IPI00207958.1 11, 7 (11.4), 0.0044 0, 0 (0.0) 0.0000 NGL-1 (LRRC 4c)
IPI00360822.3 4, 3 (5.1) 0.0016 0, 0 (0.0) 0.0000 LRRTM3
IPI00454354.1 3, 3 (4.3) 0.0012 8, 6 (5.3), 0.0101 LRRC 7
IPI00206020.1 3, 3 (19.2) 0.0012 5, 3 (11.1) 0.0063 LRRC 59
IPI00372074.1 2, 2 (4.0) 0.0008 0, 0 (0.0) 0.0000 LRRC 8
IPI00359172.2 0, 0 (0.0) 0.0000 3, 2 (5.9) 0.0038 LRRC 47
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Table 1. Continued
IPI GluA2 Spec,Pep (%AA) GluA2 Norm GluK2 Spec,Pep (%AA) GluK2 Norm Common Name
IPI00367715.3 2, 2 (3.9) 0.0008 0, 0 (0.0) 0.0000 FLRT-2
IPI00829463.1 10, 8 (7.8), 0.0040 10, 7 (6.5), 0.0127 Nrxn-1
IPI00195792.3 10, 7 (6.8), 0.0004 6, 6 (7.8), 0.0076 Nrxn-2
IPI00829491.1 5, 4 (6.1) 0.0020 4, 2 (2.7), 0.0051 Nrxn-3
IPI00325649.1 3, 2 (4.9) 0.0012 0, 0 (0.0) 0.0000 Nlgn-2
IPI00325804.1 0, 0 (0.0) 0.0000 5, 2 (3.3), 0.0063 Nlgn-3
IPI00764645.1 30, 15 (23.2), 0.0119 0, 0 (0.0) 0.0000 EphB2
IPI00189428.1 4, 3 (5.5) 0.0016 0, 0 (0.0) 0.0000 EphB1
IPI00569433.1 3, 3 (6.7), 0.0012 0, 0 (0.0) 0.0000 EphA4
IPI00230960.1 2, 2 (4.8), 0.0008 0, 0 (0.0) 0.0000 EphA5
IPI00365395.2 2, 2 (13.4) 0.0008 0, 0 (0.0) 0.0000 EphrinB2
IPI00411236.1 10, 7 (8.1), 0.0040 13, 8 (9.3), 0.0165 Latrophilin 1
IPI00561212.4 9, 8 (9.2), 0.0036 0, 0 (0.0) 0.0000 Latrophilin 3
IPI00568123.2 4, 3 (4.3) 0.0016 0, 0 (0.0) 0.0000 Latrophilin 2
IPI00568245.2 0, 0 (0.0) 0.0000 480, 136 (57.5), 0.6076 myosin 18
IPI00193933.3 3, 3 (6.0) 0.0012 0, 0 (0.0) 0.0000 DHHC5
IPI00357941.4 7, 7 (5.8) 0.0028 0, 0 (0.0) 0.0000 RTPT delta
IPI00231945.4 3, 2 (3.3) 0.0012 0, 0 (0.0) 0.0000 RTPT
IPI00565098.2 30, 13 (25.8), 0.0119 0, 0 (0.0) 0.0000 GSG1L
IPI00939232.1 2, 2 (5.1) 0.0008 0, 0 (0.0) 0.0000 Shisa-6
IPI00214724.3 4,20 (12.1), 0.0016 0, 0 (0.0) 0.0000 PPRT 1
IPI00366048.3 38, 10 (38.1) 0.0150 0, 0 (0.0) 0.0000 PPRT 2
IPI00207495.3 0, 0 (0.0) 0.0000 32, 13 (24.5), 0.0405 pentraxin-2 (Narp)
IPI00192125.1 0, 0 (0.0) 0.0000 58, 19 (29.9), 0.0734 pentraxin-1
IPI00212317.1 0, 0 (0.0) 0.0000 69, 16 (36.6), 0.0873 pentraxin receptor
IPI00206558.4 19, 9 (15.1), 0.0075 0, 0 (0.0) 0.0000 Olfm1
IPI00337161.1 5, 3 (8.7) 0.0020 0, 0 (0.0) 0.0000 Olfm3
Known primary interactors and candidate interactors are listed by common name and IPI number. The spectrum count (Spec), peptide count (Pep),
and coverage percentage (%AA) identified by LC-MS/MS aswell as the normalized (Norm) abundance of the protein relative to the immunoprecipitated
target protein are listed for proteins in both the GluA2 (A2) and GluK2 (K2) preparations. The current annotated rat protein database does not provide
complete representation of the proteins in the rat genome. Thus, to identify Shisa-6, Shisa-9, and Neto1 (shown in italics), we searched against
a concatenated database consisting of the human-mouse-rat protein databases. References of known and candidate interactors are provided in
the Extended Discussion. Black dots represent proteins that were also found in a smaller-scale duplication experiment.
(See Table S1 for full lists.)in the absence of stg or GSG1L (Figure S3C). Glutamate in the
media thus triggered the cell death by activating AMPA-Rs
whose function was enhanced by stg or GSG1L.
GSG1L Profoundly Slows AMPA-R Recovery
from the Desensitized State
TARPs, which are distantly related to GSG1L (Figures 1B and
1C), alter AMPA-R gating kinetics (Tomita et al., 2005). Specifi-
cally, deactivation and desensitization rates are slowed by
both type I and type II TARPs (with the exception of g-5; Jackson
and Nicoll, 2011), and recovery from desensitization is acceler-
ated (Priel et al., 2005).
To examine GSG1L’s potential function, we coexpressed it
with GluA2-Q (flip) in HEK 293T cells. Channel kinetics were
assessed by ultrafast agonist application to outside-out
membrane patches. In response to a sustained L-glutamate
pulse (10 mM for 100 ms), the GSG1L AMPA-R complex desen-sitized approximately 2-fold more slowly (data were fitted with
two exponentials; weighted tdes = 4.76 ± 0.16 ms, n = 27, versus
9.50 ± 0.21 ms, n = 10; p < 0.0001; t test) (Figures 2C and 2D [left
bar graph]). This difference is largely due to an increase in the
relative amplitude of the slow component of the decay (Aslow =
10 ± 2% and 47 ± 5% without and with GSG1L, respectively)
and, to a lesser extent, to an increase in the time constants of
the individual components (tfast and tslow shift from 4.09 ±
0.13 ms and 11.58 ± 0.85 ms to 4.86 ± 0.40 ms and 15.18 ±
0.82 ms, respectively). In addition, the 20%–80% rise time of
these responses was also slightly slower with GSG1L (0.23 ±
0.02 ms versus 0.19 ± 0.01 ms; p < 0.05; t test).
A more dramatic effect surfaced when recovery from desensi-
tization was analyzed via a two-pulse protocol. Whereas GluA2
recovered with a time constant of 18 ± 1 ms (n = 10), the pres-
ence of GSG1L slowed recovery by 10-fold (trec = 196 ±
28 ms, n = 6; p < 0.005, Mann-Whitney U test) (Figures 2D [rightCell Reports 1, 590–598, June 28, 2012 ª2012 The Authors 593
Figure 1. Comparative Interactomes of Native AMPA-R and KA-R Identify GSG1L as an AMPA-R-Interacting Protein
(A) Graphical representation of proteins identified as interacting with GluA2 (top) and GluK2 (bottom). Each dot represents a protein identified by mass spec-
trometry. The-y axis is the number of peptides (log scale) and the x axis represents the number of spectra in which the identified proteins were found. The black
dots are the bait protein receptor subunits. Other known interactor protein families are highlighted by different color dots (see legend). The larger dots indicate
known interactors, whereas the smaller dots indicate potential candidates. Note the location of GSG1L between data points for stg and CNIH-2.
(B) Phylogenic tree of representative proteins in claudin family constructed using neighbor-joining algorithm in CLUSTALW. The red, yellow, green, and blue
circles represents families of GSG, stg/TARPs, gamma subunit of calcium channels, and conventional claudins.
(C) Topology of GSG1L (magenta) and TARPs (gray) relative to the membrane. TM1-4 = transmembrane domain 1-4, loop1-2 = extracellular loop 1-2, CTD =
C-terminal domain. GSG1L loop1 is 50% longer compared to TARPs.
(D) Left: CBB staining of purified native AMPA-Rs. Fractions 1–6 are consecutive elutions from the antibody column using antigen peptide. Right:Western blots of
same fractions probed with anti-GluA2CT (aGluA2). Molecular weight markers are on the left (kDa) (D1). The duplicated membranes resolving the fractions in D1
were probed with anti-pan-TARP and anti-GSG1L (three different antibodies; Lp1, Ct1, and Ct2, each recognizing different epitopes) antibodies. GSG1L cop-
urifies with AMPA-Rs from rat brain (D2).
(E) Western blots of the input and immunoprecipitate (IP). (E1) Stable HEK cell line expressing GluA2flip was transfected with plasmids expressing GSG1LctHA
(ctHA indicates an HA tag at the C terminus), HA-Neto2, and EGFP. Cellular lysates were IPed using anti-HA antibody. The Western blot was probed with
antibodies indicated on right. The arrow indicates the IgG derived from the antibody used for IP. (E2) An experiment similar to that illustrated in panel E1 was
conducted, but with the use of a stable HEK cell line expressing GluK2.
(F) Confocal images of HEK cells coexpressing GSG1LctHA and GluA2. Scale bar = 10mm (upper) and 2.5 mm (lower).
(G) HEK cells were transfected with plasmids expressing the proteins indicated at the top of each lane. FLAG tagged GluA1 and 2 subunits were affinity purified
using FLAG beads. The bound protein was eluted using FLAG epitope peptide. Western blots were conducted using the indicated antibodies. mVenus variant of
EYFP was used as a negative control.
(See Figures S1 and S2 as well.)
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Figure 2. Functional Modulation of AMPA-R by GSG1L
(A) Cell surface staining of GluA2 in HEK cells cotransfected with plasmids
expressing the proteins indicated above each image. Scale bar = 200mm.
Insets are representative enlarged views.
(B) Bar graph summarizing the quantification obtained from C. *** and * indi-
cate, respectively, p < 0.0003 and p < 0.0166 against control experiments
using EGFP according to Bonferroni’s corrected student t test. The vertical
axis represents arbitrary units of fluorescence intensity.
(C) Example current responses of outside-out patches from HEK293T cells
expressing GluA2-Q(flip) without (black) or with (red) GSG1L to a 100 ms
application of 10 mM L-Glu (holding potential 60 mV). Data were fitted with
two exponentials. The weighted tdes of the traces presented here is 5.55 ms
and 10.70 ms in the absence and presence of GSG1L, respectively.
(D) Summary bar graph for the time constants of desensitization (left) and
recovery from desensitization (right). Data are presented as mean ± SEM.
****p < 0.0001 (t test); **p < 0.005 (Mann-Whitney U test).
(E) Representative current traces of outside-out patches from HEK293T cells
expressing GluA2-Q(flip) demonstrating recovery from desensitization in the
presence (red) or absence (black) of GSG1L. The paired-pulse protocol con-
sisted of a 100 ms pulse of 10 mM L-Glu followed by a 10 ms pulse in an
interval increasing by 10 ms (only selected sweeps are shown). Traces are
peak-scaled to the amplitude of the first pulse. Dashed lines indicate the
single-exponential fits of the recovery (trec = 15 ms and 140 ms for GluA2-
Q(flip) without and with GSG1L, respectively; summarized in D).
(See Figure S3 as well.)bar graph] and 2E). Interestingly, despite the structural similarity
between GSG1L and TARPs (Figures 1C and S1D), this recovery
phenotype is in fact opposite of what has been described for
TARPs acting on GluA1 but parallels the effect of CKAMP44,
a structurally unrelated Cys-knot protein (von Engelhardt et al.,
2010). However, GSG1L and CKAMP44 have opposite effects
on modulation of desensitization. Therefore, GSG1L is an
auxiliary factor that confers newly identified gating properties,
further increasing the AMPA-R functional repertoire. Collectively,
these data establish the existence of a functional interaction
between GSG1L and AMPA-Rs.Localization of GSG1L in Neurons
The in situ hybridization data in the Allen Brain Atlas indicate
GSG1L RNA signals in the hippocampus, striatum, and cortex
(Lein et al., 2007). Consistently, GSG1L immunoreactivity was
detected in CA3 pyramidal neurons and partially colocalized
with excitatory synaptic marker PSD-95 (Figure 3A). Despite
our efforts, none of the antibodies generated could detect
endogenous GSG1L in dissociated cultured cortical or hippo-
campal neurons. However, our antibodies could detect GSG1L
when it was moderately overexpressed in cultured neurons.
We speculate that our antibodies do not have affinity high
enough to detect the endogenous proteins in cultured neurons
and/or that the expression level of GSG1L in culture is lower
than that in brain tissue.
To gain insight into the distribution of GSG1L in neurons, we
analyzed the subcellular localization of GSG1L transfected into
cortical neurons. To detect GSG1L at the neuronal cell surface,
we used a GSG1L construct with an HA epitope tag in the extra-
cellular loop1 (see Experimental Procedures). Consistent with
the physical and functional interactions described above,
surface GSG1L colocalized with endogenous AMPA-R subunits
GluA1 and GluA2 (Figures 3B and 3C). The punctate subcellular
distribution of surface GSG1L also colocalized with the excit-
atory synapticmarker PSD-95 (Figure 3D). These results suggest
that GSG1L exists at the excitatory synapses in neurons where
AMPA-Rs are present.DISCUSSION
Interactome Data Identify Candidates Forming
the iGluR Complex
By searching through the data set for membrane proteins that
specifically copurify with AMPA-Rs and homologs of known
interactors, we reduced the list of candidates significantly. After
taking into account the s.c.’s and p.c.’s, we thought it likely
that GSG1L is a biologically significant AMPA-R interactor
(Figure 1A). Validation of the interaction is the rate-limiting
step, requiring multiple experimental approaches. Additional
investigations of other candidates from our data are expected
to validate additional components of AMPA-R and KA-R
complexes (see Extended Discussion).GSG1L Is an AMPA-R-Specific Auxiliary Subunit
The GSG1L gene is implicated as playing roles in the nervous
system. Its transcript level increases during synapse formationCell Reports 1, 590–598, June 28, 2012 ª2012 The Authors 595
Figure 3. Localization of GSG1L in Neurons
(A) Confocal images of sections of rat hippocampus stained with anti-GSG1L
antibody Lp1 and preimmune serum control (pre). Sections were double
stained with PSD-95, Scale bar = 50 mm (upper) and 2 mm (lower). Arrows
indicate colocalizing puncta.
(B) Confocal images of dissociated cortical neurons overexpressing HA
tagged GSG1L. The HA tag is in the extracellular loop enabling surface
596 Cell Reports 1, 590–598, June 28, 2012 ª2012 The Authors(Bruse´s, 2010; Lai et al., 2011) and decreases in Huntington’s
disease (Becanovic et al., 2010).
Both GSG1L and TARPs are members of the tetraspanin
superfamily, with GSG1L belonging to the evolutionarily distant
claudin family. The extracellular loop1 of GSG1L is least
conserved (19% homology and 6.25% identity) when
compared with stg/TARPs and is substantially longer (50%)
(Figures 1C and S1D). Because this loop is essential for
ion channel modulation by stg/TARPs (Menuz et al., 2008;
Tomita et al., 2005), divergence in AMPA-R channel modula-
tion may be due to mechanistic differences in how the
loop interacts with AMPA-Rs. Indeed, whereas TARPs speed
recovery from the desensitized state, GSG1L slows this
parameter, mimicking the structurally unrelated Cys-knot
protein CKAMP44 (von Engelhardt et al., 2010). Given that
desensitization and recovery from the desensitized state have
an impact on high-frequency transmission (Arai and Lynch,
1998), synaptic AMPA-Rs associated with GSG1L are not
expected to follow high-frequency trains with great fidelity.
Additional experiments are necessary to define the mecha-
nisms of binding and functional modulation between GSG1L
and TARPs with AMPA-Rs.
Although stg/TARPs increase surface expression of AMPA-Rs
in HEK cells, there was no change in the amplitude of the AMPA-
Rmediated current in neurons overexpressing stg (Kessels et al.,
2009). Increased surface expression of AMPA-Rs by GSG1L in
HEK cells may not warrant such modulation occurring in
neurons. Additional experiments are needed to investigate the
differences and similarities between GSG1L and stg/TARPs in
the modulation of synaptic physiology.
GSG1L is structurally related to stg/TARPs yet confers
completely different function to AMPA-Rs; therefore, investi-
gating homologs of known interactors may reveal more about
the functional repertoire of AMPA-Rs. In fact, we identified
many related proteins of known interactors (Tables 1 and S1).
For example, the LRRC and Shisa families of proteins are related
to known AMPA-R interactors LRRTM2 and CKAMP44 (de
Wit et al., 2009; Pei and Grishin, 2012). Similarly, PRRT 1
(NG5 and synDIG4), and pancortin-3 (Olfm1) are shown to cop-
urify with AMPA-Rs (von Engelhardt et al., 2010). Our study
extends the interactome by identifying homologs such as
PRRT 2 and Olfm3.
Given the large number of auxiliary subunits identified for
AMPA-Rs, questions regarding their distribution in the brain
and their stoichiometry remain. Different auxiliary subunits simul-
taneously interact with a single tetramer of GluA subunits (Kato
et al., 2010). AMPA-R complexes with different molecular
composition may be used during spatiotemporal regulation inlabeling. GSG1L expressed at the cell surface (red) and colocalizes with GluA2
(green). Upper panels; low magnification. Lower panels; enlarged view of the
dendrite. The single scale bar corresponds to 20 mm for the upper and 2 mm for
the lower panels. Arrows indicate colocalizing puncta.
(C) A similar experiment as B was conducted using anti-GluA1 antibody.
GSG1L (red) expressed at the cell surface colocalizes with GluA1 (green).
(D) A similar experiment as B was conducted using anti-PSD-95 antibody.
GSG1L (green) expressed at the cell surface partially colocalizes with
PSD-95 (red).
specific neurons and synapses. Exactly how this extensive diver-
sity contributes to the activity of neural circuits and behavior
remains unclear and is an important question that still needs to
be addressed.
EXPERIMENTAL PROCEDURES
Purification of AMPA and KA-Rs from Brain
Purification of AMPA-Rs and KA-Rs from rat brain was performed according to
previous protocols used for single-particle EM study of native AMPA-Rs
(Nakagawa et al., 2005). All experiments involving animal tissues were per-
formed according to procedures approved by the Institutional Animal Care
and Use Committee at UCSD.
Mass Spectrometry
Tryptic digests of resuspended TCA precipitates were subjected to Multidi-
mensional Protein Identification Technology (MudPIT) (Washburn et al.,
2001). Low-resolution LTQ mass spectrometers were utilized for rat samples,
and high-resolution LTQ Orbitrap Velos were used for human samples. The.
RAW and parameter files will be publicly available at http://fields.scripps.
edu/published/iGluR upon publication.
Plasmid DNA Construction
Rat GSG1L cDNA was synthesized (Genscript) on the basis of GenBank entry
XP_574558.2 and tagged with HA or FLAG. The expression plasmids pTREt,
pIRESmcherry (Clontech), and pBOSS (Shanks et al., 2010) were used.
Coimmunoprecipitation Experiments
HEK cells were transfected with various expression plasmids, and the cellular
lysates were prepared from detergent extracts. Anti-HA, -FLAG, -GluA2CT,
and -GluK2CT antibodies were used for immunoprecipitation.
Generation of Stable TetON HEK Cell Lines
Cell lines were generated with the use of previously describedmethods (Farina
et al., 2011; Shanks et al., 2010).
Surface Labeling of GluA2 in HEK Cells
TetONHEK cells (Clontech) were transfected with appropriate pTREt plasmids
in order to coexpress GluA2 together with GSG1L, stg, or EGFP. Surface
GluA2 was live labeled with an anti-GluA2-NTD antibody (1:100, Chemicon
MAB397).
Neuron Transfection and Surface Labeling
Embryonic day 18 cortical culture and surface labeling were performed as
previously described (Shanks et al., 2010; Sala et al., 2003) with slight
modifications.
Electrophysiology
Voltage-clamp recordings were performed on outside-out patches from HEK
293T cells as described previously (Rossmann et al., 2011).
Immunohistochemistry
A6-week-old rat (male) was anesthetized and fixed by perfusionwith the use of
4% paraformaldehyde in normal rat Ringer solution; 40 mm cryostat brain
sections were used.
SUPPLEMENTAL INFORMATION
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